BE887151A - Combinaisons de cetones et de composes heterocycliques compositions en comprenant outre leur preparation et leur utilisation en medecine - Google Patents

Combinaisons de cetones et de composes heterocycliques compositions en comprenant outre leur preparation et leur utilisation en medecine

Info

Publication number
BE887151A
BE887151A BE0/203540A BE203540A BE887151A BE 887151 A BE887151 A BE 887151A BE 0/203540 A BE0/203540 A BE 0/203540A BE 203540 A BE203540 A BE 203540A BE 887151 A BE887151 A BE 887151A
Authority
BE
Belgium
Prior art keywords
ketones
medicine
combinations
preparation
heterocyclic compounds
Prior art date
Application number
BE0/203540A
Other languages
English (en)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of BE887151A publication Critical patent/BE887151A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
BE0/203540A 1980-01-21 1981-01-20 Combinaisons de cetones et de composes heterocycliques compositions en comprenant outre leur preparation et leur utilisation en medecine BE887151A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8001910 1980-01-21

Publications (1)

Publication Number Publication Date
BE887151A true BE887151A (fr) 1981-07-20

Family

ID=10510765

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/203540A BE887151A (fr) 1980-01-21 1981-01-20 Combinaisons de cetones et de composes heterocycliques compositions en comprenant outre leur preparation et leur utilisation en medecine

Country Status (13)

Country Link
US (2) US4571395A (fr)
JP (1) JPS56104819A (fr)
AU (1) AU552261B2 (fr)
BE (1) BE887151A (fr)
CA (1) CA1166157A (fr)
CH (1) CH647150A5 (fr)
DE (1) DE3101644A1 (fr)
FR (1) FR2473884B1 (fr)
IT (1) IT1142259B (fr)
NL (1) NL8100259A (fr)
NZ (1) NZ196048A (fr)
SE (1) SE8100276L (fr)
ZA (1) ZA81380B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE33994E (en) * 1983-08-16 1992-07-14 Burroughs Wellcome Co. Pharmaceutical delivery system
DE3685766T2 (de) * 1985-04-18 1993-02-11 Oki Electric Ind Co Ltd Photolackbildherstellungsverfahren.
US5206238A (en) * 1990-11-13 1993-04-27 Merck & Co., Inc. Cholecystokinin antagonists
GB9217295D0 (en) * 1992-08-14 1992-09-30 Wellcome Found Controlled released tablets
US5541231A (en) * 1993-07-30 1996-07-30 Glaxo Wellcome Inc. Stabilized Pharmaceutical
GB9315856D0 (en) * 1993-07-30 1993-09-15 Wellcome Found Stabilized pharmaceutical
US5358970A (en) * 1993-08-12 1994-10-25 Burroughs Wellcome Co. Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
US7098206B2 (en) * 1998-01-21 2006-08-29 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6998400B2 (en) * 1998-01-22 2006-02-14 Smithkline Beecham Corporation Pharmaceutically active morpholinol
JP2002501892A (ja) * 1998-01-29 2002-01-22 セプラコア インコーポレーテッド 光学的に純粋な（−）−ビュープロピオンの薬学的使用
US6458374B1 (en) 1998-01-29 2002-10-01 Sepracor, Inc. Methods and compositions for treating chronic disorders using optically pure (+)-bupropion
US6734213B2 (en) 1999-01-20 2004-05-11 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6855820B2 (en) * 1999-01-20 2005-02-15 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US8545880B2 (en) * 1999-02-26 2013-10-01 Andrx Pharmaceuticals, Llc Controlled release oral dosage form
US6210716B1 (en) 1999-02-26 2001-04-03 Andrx Pharmaceuticals, Inc. Controlled release bupropion formulation
US6342496B1 (en) * 1999-03-01 2002-01-29 Sepracor Inc. Bupropion metabolites and methods of use
US6337328B1 (en) 1999-03-01 2002-01-08 Sepracor, Inc. Bupropion metabolites and methods of use
US6863901B2 (en) * 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
US6893660B2 (en) * 2002-11-21 2005-05-17 Andrx Pharmaceuticals, Inc. Stable pharmaceutical compositions without a stabilizer
WO2008105920A1 (fr) * 2007-02-28 2008-09-04 Collegium Pharmaceutical, Inc. Combinaison d'antihistaminiques
US8999393B1 (en) * 2013-01-09 2015-04-07 Edgemont Pharmaceuticals Llc Sustained release formulations of lorazepam
WO2022082058A1 (fr) * 2020-10-16 2022-04-21 Eleusis Therapeutics Us, Inc. Méthode de traitement par alcaloïdes tryptamines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA665638A (en) * 1963-06-25 L. Bolling Charles Ataractic compositions
FR2817M (fr) * 1962-07-02 1964-09-28 Merck & Co Inc Associations de médicaments pour le traitement des désordres mentaux.
NL136835C (fr) * 1965-12-03
GB1340032A (en) * 1969-12-04 1973-12-05 Wellcome Found Biologically active ketones
BE793775A (fr) * 1972-01-10 1973-07-09 Hoffmann La Roche Procede pour la stabilisation de comprimes pharmaceutiques
US4017619A (en) * 1973-10-26 1977-04-12 Burnap Raymond W Anesthetic and sedative composition

Also Published As

Publication number Publication date
NL8100259A (nl) 1981-08-17
DE3101644A1 (de) 1981-12-03
CH647150A5 (de) 1985-01-15
CA1166157A (fr) 1984-04-24
IT8147598A0 (it) 1981-01-20
FR2473884B1 (fr) 1985-06-07
IT1142259B (it) 1986-10-08
FR2473884A1 (fr) 1981-07-24
US4571395A (en) 1986-02-18
US4798826A (en) 1989-01-17
JPS56104819A (en) 1981-08-20
AU6633681A (en) 1981-07-30
NZ196048A (en) 1984-07-31
ZA81380B (en) 1982-08-25
AU552261B2 (en) 1986-05-29
SE8100276L (sv) 1981-07-22

Similar Documents

Publication Publication Date Title
BE887151A (fr) Combinaisons de cetones et de composes heterocycliques compositions en comprenant outre leur preparation et leur utilisation en medecine
BE885255A (fr) Composes de 10-deazaminopterine, leur preparation et leur utilisation
IT1211936B (it) Chetoni triciclici,procedimento per prepararli e composizioni farmaceutiche che li contengono
BE879528A (fr) Derives de 1-piperazine-carboxamides et -carbothioamides substitues, leur preparation et leur utilisation
IL55557A0 (en) New imidazole derivatives,their preparation and pharmaceutical compositions containing them
BE889401A (fr) 10-alcynyl steroides, leur preparation et leur utilisation
BE882601A (fr) Mercaptoacyldipeptides, leur preparation et leur utilisation
BE867531A (fr) N-acetyl-para-aminophenyl-n'-acetyl-aminothioalcanates, leur preparation et compositions en contenant
IL81874A0 (en) Substituted thiazoles and oxazoles,their preparation and pharmaceutical compositions containing them
FR2439197B1 (fr) 1-thia-3-aza-4-ones, substituees, leur preparation et leur utilisation en agriculture
IL60472A (en) Substituted heterocyclic phenoxyamines,their preparation and pharmaceutical compositions containing them
IT1196411B (it) Derivati ergolinici,loro preparazione e composizioni terapeutiche che li contengono
ZA803435B (en) Compositions containing toxicants, their preparation and their use
BE887323A (fr) 17alpha-acyloxy-5 beta-corticoides et 17alpha-acyloxy-5alpha-corticoides, leur preparation et leur utilisation
BE885117A (fr) 3-amino-oxazolidin-2-ones, leur preparation et leur utilisation
FR2474498B1 (fr) Derives de bis-moranoline et leur utilisation pour inhiber l'augmentation de sucre dans le sang
SE7811491L (sv) Ny polysackarid, forfarande for framstellning derav samt hypokolesterolkomposition innehallande den nya foreningen
BE888525A (fr) Nucleoside de la classe des desazapurines, compositions en contenant et leur application en medecine,
IL58648A0 (en) 7-chloro-3-alkoxycarbonyl-5-haolophenyl-2-oxo-2,3-dihydro-1,4-benzo-diazepine derivatives their preparation and pharmaceutical compositions containing them
BE894056A (fr) 2-oxo-azetidines, leur preparation et leur utilisation
IT1200163B (it) 8alfa-acilamminoergoline, loro preparazione e composizioni farmaceutiche che le contengono
DE3168343D1 (en) Monoazopigments containing heterocyclic nuclei, their preparation and use
BE879729A (fr) Composes azotes ortho-condenses tricycliques, leur preparation et leur utilisation
BE884990A (fr) Thiadiazine-amines, leur preparation et leur utilisation
BE887471A (fr) Derives benzylideniques, leur preparation et leur utilisation

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: THE WELLCOME FOUNDATION LTD

Effective date: 19870131